Sandow J
Clin Endocrinol (Oxf). 1983 Jun;18(6):571-92. doi: 10.1111/j.1365-2265.1983.tb00595.x.
The physiological requirement for activation of pituitary gonadotrophin secretion by pulsatile LHRH stimulation is discussed, and compared with the effect of pituitary stimulation by LHRH agonists. Initial stimulation is followed by a phase of progressive pituitary and gonadal inhibition. This inhibition is fully reversible at the end of agonist treatment. Clinical applications of high dose suppression are the treatment of precocious puberty and hormone-dependent tumours (mammary and prostatic carcinoma). In women, agonist administration by nasal spray is a reversible method of inhibiting ovulation, and may also be useful in the treatment of endometriosis. Clinical advantages of agonist therapy are favourable biological tolerance, lack of side effects and rapid reversibility.
讨论了通过脉冲式促黄体生成素释放激素(LHRH)刺激激活垂体促性腺激素分泌的生理需求,并与LHRH激动剂刺激垂体的效果进行了比较。初始刺激之后是垂体和性腺逐渐抑制的阶段。这种抑制在激动剂治疗结束时是完全可逆的。高剂量抑制的临床应用包括性早熟和激素依赖性肿瘤(乳腺癌和前列腺癌)的治疗。在女性中,通过鼻喷雾剂给予激动剂是抑制排卵的一种可逆方法,也可能有助于治疗子宫内膜异位症。激动剂疗法的临床优势在于良好的生物学耐受性、无副作用和快速可逆性。